belzutifan News

Latest Articles

• Phase 3 LITESPARK 022 study establishes new oral combination therapy for preventing kidney cancer recurrence after surgery

  Published: Mar 2, 2026

  Section: Health Technology

  A global clinical trial has demonstrated that combining the HIF 2α inhibitor belzutifan with standard immunotherapy significantly reduces the risk of relapse in patients with clear...

• Phase 3 trial shows belzutifan and pembrolizumab combination reduces kidney cancer recurrence risk after surgery

  Published: Mar 2, 2026

  Section: Health

  Patients with clear cell renal cell carcinoma at high risk of relapse demonstrated improved disease free survival when treated with a combination of belzutifan and pembrolizumab. D...